Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses

JP Genro, C Kieling, LA Rohde… - Expert review of …, 2010 - Taylor & Francis
Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric condition that affects
approximately 5.3% of children worldwide. This disorder is defined by a combination of …

A current update on ADHD pharmacogenomics

C Kieling, JP Genro, MH Hutz, LA Rohde - Pharmacogenomics, 2010 - Future Medicine
Pharmacological treatment for attention deficit hyperactivity disorder, although highly effective,
presents a marked variability in clinical response, optimal dosage needed and tolerability. …

The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research

JB Schuch, JP Genro, CR Bastos… - American Journal of …, 2018 - Wiley Online Library
The circadian clock system drives daily rhythms in physiology, metabolism, and behavior in
mammals. Molecular mechanisms of this system consist of multiple clock genes, with …

Association of the adrenergic α2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit …

G Polanczyk, C Zeni, JP Genro… - Archives of general …, 2007 - jamanetwork.com
Context Preclinical studies have demonstrated the relevance of adrenergic α2A receptor on
the attentional process and the mechanism of action of methylphenidate hydrochloride. …

The− 1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD

C Kieling, JP Genro, MH Hutz… - American Journal of …, 2008 - Wiley Online Library
Catecholaminergic imbalance has increasingly been implicated in the pathophysiology of
attention‐deficit/hyperactivity disorder (ADHD). The enzyme dopamine‐β‐hydroxylase (DβH)…

[HTML][HTML] Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population

DC Friedrich, JP Genro, VA Sortica, G Suarez-Kurtz… - PLoS …, 2014 - journals.plos.org
The CYP2D6 enzyme is one of the most important members of the cytochrome P450 superfamily.
This enzyme metabolizes approximately 25% of currently prescribed medications. The …

[HTML][HTML] DRD4 rare variants in Attention-Deficit/Hyperactivity Disorder (ADHD): further evidence from a birth cohort study

…, AMB Menezes, GV Polanczyk, C Kieling, JP Genro… - PLoS …, 2013 - journals.plos.org
The dopamine receptor D4 (DRD4) is one of the most studied candidate genes for Attention-Deficit/Hyperactivity
Disorder (ADHD). An excess of rare variants and non-synonymous …

Glutamatergic copy number variants and their role in attention‐deficit/hyperactivity disorder

…, A Salatino‐Oliveira, JP Genro… - American Journal of …, 2014 - Wiley Online Library
Attention‐Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder
with a strong genetic component. The glutamate metabotropic receptor genes (GRMs) have …

Influence of Genomic Ancestry on the Distribution of SLCO1B1, SLCO1B3 and ABCB1 Gene Polymorphisms among Brazilians

VA Sortica, EB Ojopi, JP Genro… - Basic & clinical …, 2012 - Wiley Online Library
The frequency distribution of SNPs and haplotypes in the ABCB1, SLCO1B1 and SLCO1B3
genes varies largely among continental populations. This variation can lead to biases in …

A common haplotype at the dopamine transporter gene 5′ region is associated with attention‐deficit/hyperactivity disorder

JP Genro, GV Polanczyk, C Zeni… - American Journal of …, 2008 - Wiley Online Library
The dopamine transporter (DAT) is the major site of methylphenidate action, which is one of
the main drugs used to treat attention‐deficit/hyperactivity disorder (ADHD). Most …